Mitigate COVID-19 impact on the Construction Industry

The city-state Singapore is currently facing another wave of COVID-19 infections driven by the Omicron variants, BA.5 an...

August 22, 2022 | Monday | News
USFDA grants EUA to Novavax COVID-19 vaccine for adolescents

Novavax has announced that its COVID-19 caccine, Adjuvanted (NVX-CoV2373) has received expanded emergency use autho...

August 22, 2022 | Monday | News
Nuvaxovid gets expanded provisional approval in NZ as COVID-19 booster for adults

US-based Novavax has announced that New Zealand (NZ)'s Medsafe has granted expanded provisional approval for Nuvaxovid (...

August 18, 2022 | Thursday | News
Frontier Biotechnologies proposes treatments for acute and prolonged COVID

China-headquartered global biopharmaceutical company Frontier Biotechnologies announced positive results from the Phase ...

August 15, 2022 | Monday | News
South Korea approves Nuvaxovid COVID-19 vaccine for use in adolescents

US-based Novavax, Inc. has announced that partner, SK bioscience, has received a Post Approval Change Application approv...

August 14, 2022 | Sunday | News
ADB approves $10 M for COVID-19 vaccines in Bhutan

The Asian Development Bank (ADB) has approved a $10 million loan to help the Government of Bhutan purchase safe and effe...

August 2, 2022 | Tuesday | News
Singapore grants interim authorisation for AstraZeneca's antiviral mAb Evusheld

The Health Sciences Authority (HSA) in Singapore, in consultation with its Medicines Advisory Committee, has, gran...

August 5, 2022 | Friday | News
SK bioscience seeks European approval for COVID-19 vaccine

South Korea-based SK bioscience, a global innovative vaccine and biotech company dedicated to promoting human health fro...

August 3, 2022 | Wednesday | News
Japan approves Novavax's COVID-19 vaccine for adolescents

US-based Novavax has announced that Nuvaxovid (NVX-CoV2373) COVID-19 vaccine received expanded manufacturing and marketi...

July 28, 2022 | Thursday | News
NTU Singapore wins S$2.8 M grant for antiviral drug research

A team of scientists led by Lee Kong Chian School of Medicine (LKCMedicine) at Nanyang Technological University, Singapo...

July 26, 2022 | Tuesday | News
SK bioscience to manufacture Novavax' COVID-19 vaccine against omicron

South Korea's SK bioscience has extended its partnership with Novavax, a US-based biotechnology company specializing in ...

July 22, 2022 | Friday | News
Australia provisionally approves Moderna's COVID-19 vaccine for kids below 6 yrs

US-based Moderna has announced that the Therapeutic Goods Administration (TGA) in Australia has granted provisional regi...

July 19, 2022 | Tuesday | News
Brii Bio advances commercialisation of COVID-19 neutralizing antibody therapy in China

Brii Biosciences has announced that TSB Therapeutics (Beijing),  a joint venture majority-owned by the company, is ...

July 19, 2022 | Tuesday | News
SINOVAC COVID-19 vaccine gets EUA for kids aged 3-5 in Brazil

Sinovac Biotech, a leading provider of biopharmaceutical products in China, has announced that its COVID-19 vaccine (Cor...

July 15, 2022 | Friday | News
Australia uses machine learning to provide early warning for emerging COVID-19 variants

Researchers at the Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia’s national scie...

July 11, 2022 | Monday | News
Japan's Shionogi seeks China approval for COVID-19 treatment

Shionogi & Co., has announced that a joint venture between Shionogi and Ping An Life Insurance Company of China, , P...

July 8, 2022 | Friday | News
Brii Biosciences launches long-acting COVID-19 neutralizing antibody therapy in China

Brii Biosciences, a multi-national company developing innovative therapies for diseases with significant unmet medi...

July 11, 2022 | Monday | News
Sinovac starts Omicron-specific inactivated vaccine trial for booster use in China

A kick off ceremony was held at Gleneagles Hospital Hong Kong (Gleneagles or GHK) for initiating a clinical trial to ass...

July 5, 2022 | Tuesday | News
Korea accelerates vaccine sovereignty by developing domestic COVID-19 vaccines

SK bioscience has announced that ‘SKYCovione,’ South Korea’s first COVID-19 vaccine candidate adjuvant...

July 1, 2022 | Friday | News
China's COVID-19 Homologous Booster demonstrates cross-neutralization against Omicron

China's Clover Biopharmaceuticals, a global clinical-stage biotechnology company developing novel vaccines and biol...

June 29, 2022 | Wednesday | News
Australia's EnGeneIC brings 2nd-Gen COVID-19 vaccine against all variants

Australian biopharma company EnGeneIC is developing the world’s first COVID-19 vaccine which can offer immunity ag...

June 29, 2022 | Wednesday | News
Facilitating pandemic preparedness in the Asia Pacific through technology transfer initiatives

Asia Pacific is home to more than half of the world’s population and bears a significant burden of infectious dise...

June 27, 2022 | Monday | Influencers
Ainos COVID-19 antigen self-test receives approval for sale in Taiwan

US-based Ainos, a diversified medtech company focused on the development of novel point-of-care testing, low-dose interf...

June 24, 2022 | Friday | News
2022 Tang Prize from Taiwan honours scientists for developing COVID-19 mRNA vaccines

After the 2014 and 2016 winners for the Tang Prize in Biopharmaceutical Sciences were crowned the Nobel Prize in 2018 an...

June 20, 2022 | Monday | News
G20 meeting proposes mobilisation of financial resources to face future pandemics

During June 6 to 8 June 2022, G20 member states discuss the mobilisation of financial resources to respond to ...

June 9, 2022 | Thursday | News